HTR3A and Nausea: Other antiemetics indicated for high-emetogenic chemotherapy, i.e. 5HT3-antagonists and neurokinin antagonists, are considered clinically relevant perpetrators, since these drugs are not used to treat oxycodone-induced nausea.